rss
Ann Rheum Dis 1999;58:428-434 doi:10.1136/ard.58.7.428
  • Extended reports

Anti-inflammatory effects of systemic anti-tumour necrosis factor α treatment in human/murine SCID arthritis

  1. Hiltrud Schädlicha,
  2. Jörg Ermanna,
  3. Maria Biskopb,
  4. Werner Falkc,
  5. Frauke Sperlinga,
  6. Astrid Jüngela,
  7. Jörg Lehmannd,
  8. Frank Emmricha,
  9. Ulrich Sacka
  1. aInstitute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Germany, bPrivate Practice, Leipzig, Germany, cDepartment of Internal Medicine I, University of Regensburg, Germany, dImmunology Unit, Large Animal Medical Department, University of Leipzig, Germany
  1. Correspondence to: Dr U Sack, Institute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Linnéstrasse 3, D-04103 Leipzig, Germany.
  • Accepted 1 March 1999

Abstract

OBJECTIVES To evaluate in vivo the contribution of tumour necrosis factor α (TNFα) to the chimeric transfer model of human rheumatoid arthritis synovial membrane into SCID mice (hu/mu SCID arthritis), systemic anti-TNFα treatment was performed and the clinical, serological, and histopathological effects of this treatment assessed.

METHODS Animals were treated with the rat-antimouse TNFα monoclonal antibody V1q, starting on day 1 after hu/mu engraftment, twice weekly for 12 weeks. Joint swelling, serum concentrations of human and murine interleukin 6 (IL6), and serum amyloid P (SAP) were measured. Histopathological and immunohistochemical analyses of the joints were also performed at the end of treatment.

RESULTS Neutralisation of murine TNFα induced the following effects: (a) reduction of extent and duration of the acute arthritis phase, with significant reduction of joint swelling at two weeks; (b) decrease of murine SAP concentrations after the first antibody administration; and (c) increase of murine IL6 in the serum. At the end of treatment, there was a significant reduction of the inflammatory infiltration in the engrafted joints. Because of the mild degree of joint erosion, no treatment effects could be demonstrated on the destructive process.

CONCLUSION In the lymphocyte independent hu/mu SCID arthritis, anti-TNFα treatment reduces local and systemic signs of inflammation.

Footnotes

  • Funding: this study was supported by the Federal Ministry of Education, Science, Research, and Technology (grant 01ZZ9103); the Interdisciplinary Center for Clinical Research at the University of Leipzig (grant 01KS9504 A3); the German Research Council (DFG); and the Alexander von Humboldt Foundation (Bonn, Germay).

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.